Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pPGS-hSLUG.fl.flag Citations (6)

Originally described in: Slug plasmid
Unpublished

Articles Citing pPGS-hSLUG.fl.flag

Articles
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S. PLoS One. 2012;7(7):e40378. doi: 10.1371/journal.pone.0040378. Epub 2012 Jul 20. PubMed
Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK. Dbouk HA, Weil LM, Perera GK, Dellinger MT, Pearson G, Brekken RA, Cobb MH. Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):15999-6004. doi: 10.1073/pnas.1419057111. Epub 2014 Oct 31. PubMed
Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Tisza MJ, Zhao W, Fuentes JS, Prijic S, Chen X, Levental I, Chang JT. Oncotarget. 2016 Aug 9;7(32):51553-51568. doi: 10.18632/oncotarget.9928. PubMed
The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy. Vrenken KS, Vervoort BMT, van Ingen Schenau DS, Derks YHW, van Emst L, Grytsenko PG, Middelbeek JAJ, van Leeuwen FN. Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165644. doi: 10.1016/j.bbadis.2019.165644. Epub 2019 Dec 17. PubMed
Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma. Hensch NR, Bondra K, Wang L, Sreenivas P, Zhao XR, Modi P, Vaseva AV, Houghton PJ, Ignatius MS. Mol Cancer Ther. 2023 Jan 3;22(1):123-134. doi: 10.1158/1535-7163.MCT-22-0310. PubMed
Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells. Vogiatzoglou AP, Spanou S, Sachini N, Drakos E, Nikolaou C, Makatounakis T, Kretsovali A, Papamatheakis J. Mol Oncol. 2023 Oct;17(10):2090-2108. doi: 10.1002/1878-0261.13501. Epub 2023 Sep 4. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.